Matches in Wikidata for { <http://www.wikidata.org/entity/Q79826274> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q79826274 description "article scientifique publié en 2006" @default.
- Q79826274 description "artículu científicu espublizáu en xunetu de 2006" @default.
- Q79826274 description "im Juli 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q79826274 description "scientific article published on 01 July 2006" @default.
- Q79826274 description "wetenschappelijk artikel" @default.
- Q79826274 description "наукова стаття, опублікована в липні 2006" @default.
- Q79826274 name "Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy" @default.
- Q79826274 name "Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy" @default.
- Q79826274 type Item @default.
- Q79826274 label "Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy" @default.
- Q79826274 label "Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy" @default.
- Q79826274 prefLabel "Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy" @default.
- Q79826274 prefLabel "Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy" @default.
- Q79826274 P1433 Q79826274-7E5F15F7-BC2A-4A69-8E24-AD944E39FD4D @default.
- Q79826274 P1476 Q79826274-4F280A11-A480-4E0F-BB9C-5440C6535BA8 @default.
- Q79826274 P2093 Q79826274-2039E7B4-B599-437D-A52B-B3340FDB6315 @default.
- Q79826274 P2093 Q79826274-38E3DD1D-9DC4-440C-AF6E-CD7689162FDA @default.
- Q79826274 P2093 Q79826274-DD321893-6A28-4D87-8736-6535D781F37E @default.
- Q79826274 P304 Q79826274-4ABE821A-C2E1-4013-A763-CD864CA163DF @default.
- Q79826274 P31 Q79826274-902B23E6-2E01-4EFA-B3C7-94AA9CD1A4E8 @default.
- Q79826274 P356 Q79826274-51394277-736F-4AC1-B0EC-8E109EDAF6C1 @default.
- Q79826274 P407 Q79826274-0D27C20E-E94B-4637-8030-C914D4D38710 @default.
- Q79826274 P433 Q79826274-BDCB65EE-403B-48BC-AA8E-A8D3FE2233B7 @default.
- Q79826274 P478 Q79826274-F002078E-297D-490E-AF4B-E45E47228C05 @default.
- Q79826274 P50 Q79826274-2396C63B-4293-4201-801E-4888F5DBC9F4 @default.
- Q79826274 P577 Q79826274-8A7AF875-B30F-416B-916A-7EBB18192036 @default.
- Q79826274 P698 Q79826274-13D57B06-B303-4BA4-ABF9-0BBA417649DF @default.
- Q79826274 P921 Q79826274-3C652472-6586-469B-9138-2955B29E1385 @default.
- Q79826274 P921 Q79826274-452FDF61-59F5-4AFC-AD14-52C77F783324 @default.
- Q79826274 P921 Q79826274-D6E25BB3-3AD8-440F-8516-292E42614BEA @default.
- Q79826274 P356 J.AJO.2006.02.015 @default.
- Q79826274 P698 16815267 @default.
- Q79826274 P1433 Q4744258 @default.
- Q79826274 P1476 "Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy" @default.
- Q79826274 P2093 "Hirokazu Sakaguchi" @default.
- Q79826274 P2093 "Yasuo Tano" @default.
- Q79826274 P2093 "Yusuke Oshima" @default.
- Q79826274 P304 "155-158" @default.
- Q79826274 P31 Q13442814 @default.
- Q79826274 P356 "10.1016/J.AJO.2006.02.015" @default.
- Q79826274 P407 Q1860 @default.
- Q79826274 P433 "1" @default.
- Q79826274 P478 "142" @default.
- Q79826274 P50 Q41565670 @default.
- Q79826274 P577 "2006-07-01T00:00:00Z" @default.
- Q79826274 P698 "16815267" @default.
- Q79826274 P921 Q18967481 @default.
- Q79826274 P921 Q413299 @default.
- Q79826274 P921 Q631361 @default.